Private Advisor Group’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $10.4M | Buy |
52,611
+764
| +1% | +$147K | 0.05% | 390 |
|
|
2025
Q4 | $9.53M | Buy |
51,847
+602
| +1% | +$106K | 0.04% | 409 |
|
|
2025
Q3 | $7.86M | Buy |
51,245
+3,823
| +8% | +$579K | 0.04% | 456 |
|
|
2025
Q2 | $6.63M | Buy |
47,422
+15,890
| +50% | +$2.23M | 0.04% | 469 |
|
|
2025
Q1 | $4.64M | Sell |
31,532
-129
| -0.4% | -$18.7K | 0.03% | 563 |
|
|
2024
Q4 | $4.15M | Sell |
31,661
-601
| -2% | -$84.1K | 0.02% | 584 |
|
|
2024
Q3 | $5.03M | Sell |
32,262
-291
| -0.9% | -$47K | 0.03% | 522 |
|
|
2024
Q2 | $5.08M | Buy |
32,553
+2,278
| +8% | +$343K | 0.03% | 480 |
|
|
2024
Q1 | $4.1M | Sell |
30,275
-262
| -0.9% | -$34.7K | 0.03% | 524 |
|
|
2023
Q4 | $4.11M | Sell |
30,537
-1,944
| -6% | -$253K | 0.03% | 502 |
|
|
2023
Q3 | $4.4M | Sell |
32,481
-2,281
| -7% | -$312K | 0.04% | 432 |
|
|
2023
Q2 | $4.98M | Sell |
34,762
-1,169
| -3% | -$172K | 0.04% | 401 |
|
|
2023
Q1 | $4.99M | Buy |
35,931
+830
| +2% | +$112K | 0.05% | 378 |
|
|
2022
Q4 | $3.42M | Buy |
35,101
+778
| +2% | +$97.6K | 0.17% | 127 |
|
|
2022
Q3 | $3.76M | Sell |
34,323
-16,664
| -33% | -$2.11M | 0.04% | 421 |
|
|
2022
Q2 | $6.74M | Buy |
50,987
+1,375
| +3% | +$180K | 0.06% | 319 |
|
|
2022
Q1 | $6.58M | Buy |
49,612
+1,321
| +3% | +$158K | 0.05% | 354 |
|
|
2021
Q4 | $5.63M | Sell |
48,291
-36,835
| -43% | -$4.33M | 0.04% | 414 |
|
|
2021
Q3 | $10.2M | Buy |
85,126
+43,709
| +106% | +$5.09M | 0.07% | 296 |
|
|
2021
Q2 | $4.96M | Buy |
41,417
+42
| +0.1% | +$4.61K | 0.04% | 407 |
|
|
2021
Q1 | $4.11M | Buy |
41,375
+21,218
| +105% | +$2.13M | 0.04% | 436 |
|
|
2020
Q4 | $2.02M | Buy |
20,157
+4,233
| +27% | +$448K | 0.02% | 661 |
|
|
2020
Q3 | $1.72M | Buy |
15,924
+1,505
| +10% | +$167K | 0.02% | 608 |
|
|
2020
Q2 | $1.52M | Buy |
14,419
+878
| +6% | +$90.7K | 0.02% | 612 |
|
|
2020
Q1 | $1.21M | Buy |
13,541
+847
| +7% | +$79.7K | 0.02% | 595 |
|
|
2019
Q4 | $1.26M | Sell |
12,694
-11,193
| -47% | -$1.05M | 0.02% | 678 |
|
|
2019
Q3 | $2.23M | Buy |
23,887
+2,261
| +10% | +$196K | 0.03% | 508 |
|
|
2019
Q2 | $1.74M | Buy |
21,626
+8,002
| +59% | +$627K | 0.03% | 527 |
|
|
2019
Q1 | $1.1M | Buy |
13,624
+3,161
| +30% | +$249K | 0.02% | 620 |
|
|
2018
Q4 | $795K | Sell |
10,463
-6,066
| -37% | -$474K | 0.02% | 660 |
|
|
2018
Q3 | $1.31M | Sell |
16,529
-15,711
| -49% | -$1.19M | 0.03% | 569 |
|
|
2018
Q2 | $2.26M | Buy |
32,240
+23,232
| +258% | +$1.67M | 0.04% | 254 |
|
|
2018
Q1 | $630K | Sell |
9,008
-17,028
| -65% | -$1.18M | 0.02% | 573 |
|
|
2017
Q4 | $1.83M | Buy |
26,036
+6,389
| +33% | +$431K | 0.08% | 258 |
|
|
2017
Q3 | $1.35M | Buy |
19,647
+3,434
| +21% | +$217K | 0.03% | 485 |
|
|
2017
Q2 | $1.09M | Sell |
16,213
-14,401
| -47% | -$940K | 0.03% | 518 |
|
|
2017
Q1 | $1.66M | Buy |
30,614
+18,625
| +155% | +$1.08M | 0.05% | 390 |
|
|
2016
Q4 | $674K | Buy |
11,989
+3,335
| +39% | +$189K | 0.02% | 630 |
|
|
2016
Q3 | $565K | Sell |
8,654
-718
| -8% | -$46.9K | 0.02% | 607 |
|
|
2016
Q2 | $564K | Buy |
9,372
+1,344
| +17% | +$78.1K | 0.02% | 587 |
|
|
2016
Q1 | $452K | Sell |
8,028
-872
| -10% | -$52.4K | 0.02% | 611 |
|
|
2015
Q4 | $604K | Buy |
8,900
+1,045
| +13% | +$68.5K | 0.03% | 536 |
|
|
2015
Q3 | $500K | Buy |
7,855
+102
| +1% | +$6.71K | 0.03% | 574 |
|
|
2015
Q2 | $494K | Buy |
7,753
+166
| +2% | +$11.4K | 0.02% | 596 |
|
|
2015
Q1 | $519K | Sell |
7,587
-296
| -4% | -$20.6K | 0.03% | 546 |
|
|
2014
Q4 | $555K | Sell |
7,883
-4,194
| -35% | -$300K | 0.04% | 502 |
|
|
2014
Q3 | $863K | Buy |
12,077
+10
| +0.1% | +$732 | 0.06% | 360 |
|
|
2014
Q2 | $897K | Sell |
12,067
-578
| -5% | -$41.8K | 0.08% | 314 |
|
|
2014
Q1 | $820K | Sell |
12,645
-445
| -3% | -$28.7K | 0.09% | 284 |
|
|
2013
Q4 | $777K | Buy |
+13,090
| New | +$711K | 0.09% | 284 |
|
Other funds holding AZN
IA
VCM
VAM
Private Advisor Group's AZN Position: Q1 2026 in Review
Private Advisor Group increased its AstraZeneca (AZN) stake by 1.5% in Q1 2026, buying an estimated $147K and bringing the position to 52,611 shares worth $10.4M. The position accounts for 0.05% of the portfolio, ranked #390.
Private Advisor Group first reported a position in AZN in Q4 2013 and has held it in 50 quarters since. 1,377 funds tracked by Wall St. Rank hold AZN as of Q1 2026.
- Private Advisor Group held 52,611 shares of AstraZeneca worth $10.4M as of Q1 2026.
- Private Advisor Group bought 764 AstraZeneca shares in Q1 2026, an estimated $147K.
- AstraZeneca made up 0.05% of Private Advisor Group's portfolio in Q1 2026, its #390 holding.
- Private Advisor Group first reported a position in AstraZeneca in Q4 2013 and has held it in 50 quarters since.
- 1,377 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.
Based on Private Advisor Group's 13F filing for Q1 2026, filed 27 Apr 2026.